Eton Pharmaceuticals (ETON) Retained Earnings: 2019-2025
Historic Retained Earnings for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to -$114.0 million.
- Eton Pharmaceuticals' Retained Earnings fell 6.23% to -$114.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.0 million, marking a year-over-year decrease of 6.23%. This contributed to the annual value of -$107.9 million for FY2024, which is 3.67% down from last year.
- Eton Pharmaceuticals' Retained Earnings amounted to -$114.0 million in Q3 2025, which was down 1.72% from -$112.0 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Retained Earnings ranged from a high of -$87.0 million in Q1 2021 and a low of -$114.0 million during Q3 2025.
- Moreover, its 3-year median value for Retained Earnings was -$107.3 million (2024), whereas its average is -$106.9 million.
- Per our database at Business Quant, Eton Pharmaceuticals' Retained Earnings fell by 18.85% in 2021 and then increased by 2.15% in 2023.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Retained Earnings stood at -$94.1 million in 2021, then declined by 9.59% to -$103.1 million in 2022, then fell by 0.91% to -$104.1 million in 2023, then decreased by 3.67% to -$107.9 million in 2024, then declined by 6.23% to -$114.0 million in 2025.
- Its last three reported values are -$114.0 million in Q3 2025, -$112.0 million for Q2 2025, and -$109.5 million during Q1 2025.